Damora Therapeutics, Inc. (DMRA)

Damora Therapeutics, Inc. (DMRA) is a healthcare company (biotechnology) based in the United States. The share price is $22.37, down 0.56% on the day, which values the company at $1.38B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$22.37−0.56% today
Market value
$1.38B
P/E ratio
13.1×last 12 months
200-week average
$21.076% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Damora Therapeutics, Inc. in more detail

DMRA trades at 13.1× its last twelve months' earnings, -10.2× next year's expected earnings. It sits 6% above its 200-week average of $21.07.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

2 of the superinvestors tracked here hold DMRA, including Peter Kolchinsky (0.5% of the portfolio), Andreas Halvorsen (0.2% of the portfolio).

Superinvestors holding DMRA

2 of the investors tracked here report a position in their latest 13F filing.

Damora Therapeutics, Inc. (DMRA): questions and answers

What is DMRA's P/E ratio?

Damora Therapeutics, Inc. trades at 13.1× its last twelve months' earnings and -10.2× next year's expected earnings.

What is Damora Therapeutics, Inc.'s market cap?

Damora Therapeutics, Inc. is valued at $1.38B at a share price of $22.37.

Is DMRA above its 200-week moving average?

Yes. DMRA is 6.2% above its 200-week average of $21.07. Long-term investors watch that line because strong companies rarely trade below it for long.

Does DMRA pay a dividend?

Damora Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own DMRA?

In their latest quarterly filings, Peter Kolchinsky (0.5% of the portfolio), Andreas Halvorsen (0.2% of the portfolio) hold DMRA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Damora Therapeutics, Inc. (DMRA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DMRA

Underlying data: Yahoo Finance; company filings with the SEC.